The SURMOUNT-1 trial, the landmark study that led to tirzepatide FDA approval for weight management, provides the clearest data
In simpler terms, your brain manages the testosterone production process, with the testes acting as the factories
While prior research has confirmed the benefits of semaglutide in managing blood sugar, decreasing cardiovascular disease events and reducing weight in people with Type 2 diabetes, this study specifically investigated the potential impact of semaglutide on cardiovascular disease in people with overweight or obesity and cardiovascular disease who did not have either Type 1 or Type 2 diabetes
GLP-1 Side Effects: What You Must Know Before Starting GLP-1 weight loss drugs are widely used for appetite control and fat lossbut side effects are part of the journey, especially in the first few days
Exceeding these doses is not recommended, as safety and efficacy data beyond these levels are limited
Structure's Phase 2 trial enrolled people with obesity or who are overweight and have a weight-related complication like heart disease, randomizing 61 to receive aleniglipron and 12 to receive a placebo